| Product Name | Catalog Number | CAS Number | MSDS |
|---|---|---|---|
| Tofacitinib Related Compound 30 | NVIP01453 | MSDS | |
| Tofacitinib Related Compound 31 | NVIP01454 | MSDS | |
| dehydroepiandrosterone-17-hydrazone | NV63015101 | 63015-10-1 | MSDS |
| 17-iodo-5,16-androstadien-3-ol | NV32138695 | 32138-69-5 | MSDS |
| 3-(dimethylboryl)pyridine | NV1003865868 | 1003865-86-8 | MSDS |
| pyridine-3-boronic acid dimethyl ester | NV175885775 | 175885-77-5 | MSDS |
| 3-((tert-butyldimethylsilyl)oxy)-17-iodo-5,16-androstadiene | NV1426400023 | 1426400-02-3 | MSDS |
| 3-((tert-butyldimethylsilyl)oxy)-5,16-androstadien-17-boronic acid | NV1426400034 | 1426400-03-4 | MSDS |
| 3-((tert-butyldimethylsilyl)oxy)abiraterone | NV1421704600 | 1421704-60-0 | MSDS |
| (3S)-3-tert-butyldimethylsilyloxyandrost-5-en-17-one | NV42151235 | 42151-23-5 | MSDS |
| Abiraterone acetate impurity A | NVIP01455 | MSDS | |
| Abiraterone acetate impurity B | NVIP01456 | MSDS | |
| Abiraterone acetate impurity C | NVIP01457 | 1382475-35-5 | MSDS |
| Abiraterone acetate impurity D | NVIP01458 | MSDS | |
| Abiraterone acetate impurity E | NVIP01459 | MSDS |
